Stephen A. Sherwin - Concepedia

Author

Stephen A. Sherwin

The University of Texas MD Anderson Cancer Center

Also Known As

Alpna Seth, S A Sherwin, S Sherwin, S. A. Sherwin, S. Renshaw, STEPHEN A. SHERWIN, STEPHEN SHERWIN, Sherwin, Stephen A., Stephen A Sherwin, Stephen A. Sherwin

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Institutes of Health National Cancer Institute Memorial Sloan Kettering Cancer Center Genesys (United States)

About

Stephen A. Sherwin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	34	3.1K
2	Health Sciences	8	8	626
3	Cell Biology	6	6	416
4	Allergy	2	2	357
5	Public Health	1	1	18

Stephen A. Sherwin

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Phase I study of recombinant tumor necrosis factor in cancer patients. Mark Blick, Stephen A. Sherwin, Michael G. Rosenblum, PubMed ImmunologyImmunoeditingPathologyImmunotherapeuticsCancer Patients	1987	428
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy Carl Nathan, Gilla Kaplan, William R. Levis, New England Journal of Medicine Laboratory ImmunologyMacrophage ActivationImmunodeficienciesImmunologyPathology	1986	325
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer Kristen Hege, Emily K. Bergsland, George A. Fisher, Journal for ImmunoTherapy of Cancer	2017	312
Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon Kenneth A. Foon, Stephen A. Sherwin, Paul G. Abrams, New England Journal of Medicine	1984	278
Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Razelle Kurzrock, Michael G. Rosenblum, Stephen A. Sherwin, PubMed Biological ActivityAmino AcidsNovel TherapyMedicineSingle-dose Tolerance	1985	188
Acute Interstitial Nephritis with the Nephrotic Syndrome Following Recombinant Leukocyte A Interferon Therapy for Mycosis Fungoides Steven D. Averbuch, Howard A. Austin, Stephen A. Sherwin, New England Journal of Medicine Glomerular DiseaseVasculitisRenal PathologyImmunologyPathology	1984	180
A Multiple-Dose Phase I Trial of Recombinant Leukocyte A Interferon in Cancer Patients Stephen A. Sherwin, James A. Knost, Seymour Fein, JAMA ImmunologyPathologyCancer PatientsBiological ResponseImmunotherapy	1982	150
Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. Howard Jaffe, Roland Buhl, Andrea Mastrangeli, Journal of Clinical Investigation Inflammatory Lung DiseaseLung InflammationImmunologyImmunologic MechanismLocal Activation	1991	128
High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Stephen A. Sherwin, Daniel R. Twardzik, William H. Bohn, PubMed Tumor BiologyUrologyGrowth Factor ActivityDisseminated CancerGrowth Factor	1983	122
The determination of an immunologically active dose of interferon-gamma in patients with melanoma. A E Maluish, Walter J. Urba, Daniele Longo, Journal of Clinical Oncology ImmunodeficienciesImmunologyImmunoeditingPathologyActive Dose	1988	122

Page 1